Newsroom

Newsroom

Press Releases

1 of 1

Waldencast Announces Q2 2025 Results and Provides Q3 2025 Trading Update
November 23, 2025
Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting
November 15, 2025
Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities
November 13, 2025
Waldencast plc Provides Information Regarding Upcoming Earnings Release Dates
November 11, 2025
Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum
October 7, 2025
Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand
September 10, 2025

Media Library

1 of 1